Summit Corporation Plc
Patent Applications and Registrations
Patent applications and USPTO patent grants for Summit Corporation Plc.The latest application filed is for "treatment of energy utilization disease".
- Summit Corporation Plc - Abingdon Oxfordshire GB
- Summit Corporation Plc - Abingdon Oxfordshire N/A GB
- Summit Corporation PLC - Oxfordshire GB
- Summit Corporation Plc; - Abingdon Oxfordshire GB
- SUMMIT CORPORATION PLC -
| Patent | Date |
|---|---|
| Pharmaceutical composition for the treatment of Duchenne muscular dystrophy Grant 9,492,433 - Tinsley , et al. November 15, 2 | 2016-11-15 |
| Treatment Of Energy Utilization Disease App 20160151341 - NASH; Robert James ; et al. | 2016-06-02 |
| Pharmaceutical Composition For The Treatment Of Duchenne Muscular Dystrophy App 20150238467 - Tinsley; Jonathon Mark | 2015-08-27 |
| Compounds For The Treatment Of Clostridium Difficile Associated Disease App 20150209340 - Johnson; Peter David ; et al. | 2015-07-30 |
| Antibacterial Compounds App 20150150861 - WILSON; Francis Xavier ; et al. | 2015-06-04 |
| Compounds for the treatment of Clostridium difficile-associated disease Grant 8,987,308 - Johnson , et al. March 24, 2 | 2015-03-24 |
| Antibacterial compounds Grant 8,975,416 - Davis , et al. March 10, 2 | 2015-03-10 |
| Pyrrolidine Derivatives As Selective Glycosidase Inhibitors And Uses Thereof App 20140073801 - Storer; Richard ; et al. | 2014-03-13 |
| Treatment Of Duchenne Muscular Dystrophy App 20140018320 - WYNNE; GRAHAM MICHAEL ; et al. | 2014-01-16 |
| Drug Combinations For The Treatment Of Duchenne Muscular Dystrophy App 20140011782 - WYNNE; Graham Michael ; et al. | 2014-01-09 |
| Compounds For The Treatment Of Clostridium Difficile-associated Disease App 20130309191 - Johnson; Peter David ; et al. | 2013-11-21 |
| Treatment of Duchenne muscular dystrophy Grant 8,518,980 - Wynne , et al. August 27, 2 | 2013-08-27 |
| Drug combinations for the treatment of duchenne muscular dystrophy Grant 8,501,713 - Wynne , et al. August 6, 2 | 2013-08-06 |
| Compounds For The Treatment Of Clostridium Difficile-associated Disease App 20130095057 - Johnson; Peter David ; et al. | 2013-04-18 |
| Treatment of duchenne muscular dystrophy Grant 8,138,351 - Wynne , et al. March 20, 2 | 2012-03-20 |
| Antibacterial Compounds App 20120020950 - Davis; Paul James ; et al. | 2012-01-26 |
| Treatment Of Lysosomal Storage Disorders And Other Proteostatic Diseases App 20110237538 - De Moor; Olivier ; et al. | 2011-09-29 |
| Compounds For The Treatment Of Flaviviral Infections App 20110195929 - De Moor; Olivier ; et al. | 2011-08-11 |
| Treatment of Energy Utilization Disease App 20110015226 - Nash; Robert James ; et al. | 2011-01-20 |
| Treatment Of Protein Folding Disorders App 20100317690 - Kawamura; Akane ; et al. | 2010-12-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 